{"height":"190","url":"https://uneyama.hatenadiary.jp/entry/20180831/p8","blog_url":"https://uneyama.hatenadiary.jp/","author_name":"uneyama","provider_url":"https://hatena.blog","width":"100%","title":"\u5730\u65b9\u88c1\u5224\u6240\u306f\u975e\u516c\u8868\u306e\u533b\u85ac\u54c1\u3092\u542b\u3080\u7cbe\u529b\u5264\u88fd\u54c1\u3092\u8ca9\u58f2\u3057\u3066\u3044\u308b\u4f01\u696d\u306b\u5bfe\u3057\u3066\u6052\u4e45\u7684\u306a\u5dee\u3057\u6b62\u3081\u547d\u4ee4\u3092\u4e0b\u3057\u305f\u3002","type":"rich","categories":["FDA"],"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20180831%2Fp8\" title=\"\u5730\u65b9\u88c1\u5224\u6240\u306f\u975e\u516c\u8868\u306e\u533b\u85ac\u54c1\u3092\u542b\u3080\u7cbe\u529b\u5264\u88fd\u54c1\u3092\u8ca9\u58f2\u3057\u3066\u3044\u308b\u4f01\u696d\u306b\u5bfe\u3057\u3066\u6052\u4e45\u7684\u306a\u5dee\u3057\u6b62\u3081\u547d\u4ee4\u3092\u4e0b\u3057\u305f\u3002 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","provider_name":"Hatena Blog","version":"1.0","author_url":"https://blog.hatena.ne.jp/uneyama/","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","image_url":null,"published":"2018-08-31 00:00:07","description":"District Court orders permanent injunction against companies selling sexual enhancement products containing undisclosed drugs August 30, 2018 https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm619083.htm FDA\u306e\u691c\u67fb\u3067\u88fd\u54c1\u306b\u30b7\u30eb\u30c7\u30ca\u30d5\u30a3\u30eb\u3092\u542b\u3080\u3053\u3068\u304c\u308f\u304b\u3063\u305f\u3002"}